These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1959448)

  • 41. Catalytic antibodies and biomimetics.
    Green BS
    Curr Opin Biotechnol; 1991 Jun; 2(3):395-400. PubMed ID: 1367827
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Enantioselective organocatalytic intramolecular Diels-Alder reactions. The asymmetric synthesis of solanapyrone D.
    Wilson RM; Jen WS; Macmillan DW
    J Am Chem Soc; 2005 Aug; 127(33):11616-7. PubMed ID: 16104734
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression of a functional scFv fragment of an anti-idiotypic antibody with a beta-lactam hydrolytic activity.
    Padiolleau-Lefèvre S; Débat H; Phichith D; Thomas D; Friboulet A; Avalle B
    Immunol Lett; 2006 Feb; 103(1):39-44. PubMed ID: 16325271
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Enantio- and periselective nitroalkene Diels-Alder reaction.
    Narcis MJ; Sprague DJ; Captain B; Takenaka N
    Org Biomol Chem; 2012 Dec; 10(46):9134-6. PubMed ID: 23104427
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular recognition in applied enzyme chemistry.
    Suckling CJ
    Experientia; 1991 Dec; 47(11-12):1139-1148. PubMed ID: 1765126
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oxazaborolidinone-catalyzed enantioselective Diels-Alder reaction of acyclic alpha,beta-unsaturated ketones.
    Singh RS; Adachi S; Tanaka F; Yamauchi T; Inui C; Harada T
    J Org Chem; 2008 Jan; 73(1):212-8. PubMed ID: 18052389
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The interplay between chemistry and biology in the design of enzymatic catalysts.
    Schultz PG
    Science; 1988 Apr; 240(4851):426-33. PubMed ID: 2833815
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Proline catalyzed α-aminoxylation reaction in the synthesis of biologically active compounds.
    Kumar P; Dwivedi N
    Acc Chem Res; 2013 Feb; 46(2):289-99. PubMed ID: 23148510
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Insight into a natural Diels-Alder reaction from the structure of macrophomate synthase.
    Ose T; Watanabe K; Mie T; Honma M; Watanabe H; Yao M; Oikawa H; Tanaka I
    Nature; 2003 Mar; 422(6928):185-9. PubMed ID: 12634789
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Highly enantioselective Diels-Alder reactions of Danishefsky type dienes with electron-deficient alkenes catalyzed by Yb(III)-BINAMIDE complexes.
    Sudo Y; Shirasaki D; Harada S; Nishida A
    J Am Chem Soc; 2008 Sep; 130(38):12588-9. PubMed ID: 18761458
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The kinetic basis of a general method for the investigation of active site content of enzymes and catalytic antibodies: first-order behaviour under single-turnover and cycling conditions.
    Topham CM; Gul S; Resmini M; Sonkaria S; Gallacher G; Brocklehurst K
    J Theor Biol; 2000 May; 204(2):239-56. PubMed ID: 10887904
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A catalytic antibody programmed for torsional activation of amide bond hydrolysis.
    Aggarwal R; Benedetti F; Berti F; Buchini S; Colombatti A; Dinon F; Galasso V; Norbedo S
    Chemistry; 2003 Jul; 9(13):3132-42. PubMed ID: 12833295
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Medium-Ring Effects on the Endo/Exo Selectivity of the Organocatalytic Intramolecular Diels-Alder Reaction.
    Hooper JF; James NC; Bozkurt E; Aviyente V; White JM; Holland MC; Gilmour R; Holmes AB; Houk KN
    J Org Chem; 2015 Dec; 80(24):12058-75. PubMed ID: 26560246
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regioselectivity and enantioselectivity in an antibody catalyzed hetero Diels-Alder reaction.
    Meekel AA; Resmini M; Pandit UK
    Bioorg Med Chem; 1996 Jul; 4(7):1051-7. PubMed ID: 8831976
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Catalytic antibodies with lipase activity and R or S substrate selectivity.
    Janda KD; Benkovic SJ; Lerner RA
    Science; 1989 Apr; 244(4903):437-40. PubMed ID: 2717936
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Recent Advances in Inverse-Electron-Demand Hetero-Diels-Alder Reactions of 1-Oxa-1,3-Butadienes.
    Pałasz A
    Top Curr Chem (Cham); 2016 Jun; 374(3):24. PubMed ID: 27573264
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression and characterization of recombinant single-chain Fv and Fv fragments derived from a set of catalytic antibodies.
    Kim SH; Schindler DG; Lindner AB; Tawfik DS; Eshhar Z
    Mol Immunol; 1997; 34(12-13):891-906. PubMed ID: 9464525
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tritylase antibodies.
    Iverson BL; Iverson SA; Cameron KE; Jahangiri GK; Pasternak DS; Lerner RA
    Ciba Found Symp; 1991; 159():227-33; discussion 234-5. PubMed ID: 1959450
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Homochiral metal-organic frameworks with enantiopure proline units for the catalytic synthesis of β-lactams.
    Xu ZX; Tan YX; Fu HR; Liu J; Zhang J
    Inorg Chem; 2014 Nov; 53(22):12199-204. PubMed ID: 25361035
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transition state docking: a probe for noncovalent catalysis in biological systems. Application to antibody-catalyzed ester hydrolysis.
    Tantillo DJ; Houk KN
    J Comput Chem; 2002 Jan; 23(1):84-95. PubMed ID: 11913392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.